BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11724112)

  • 21. Sentinel surveillance for Streptococcus pneumoniae antibiotic nonsusceptibility.
    Mera R
    South Med J; 2007 Jan; 100(1):4. PubMed ID: 17269516
    [No Abstract]   [Full Text] [Related]  

  • 22. Epidemiology of antibiotic-resistant Streptococcus pneumoniae strains in Far East Russia.
    Martynova AV; Turcutyuicov VB
    Int J Antimicrob Agents; 2004 Jun; 23(6):641-2. PubMed ID: 15194139
    [No Abstract]   [Full Text] [Related]  

  • 23. Is drug resistance affecting treatment outcomes?
    Bishai W
    Am J Manag Care; 2000 Dec; 6(23 Suppl):S1197-201. PubMed ID: 11187443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Resistance of Streptococcus pneumoniae to antibiotics].
    Simarro E; Ruiz J
    Rev Esp Quimioter; 1998 Dec; 11(4):353-5. PubMed ID: 10336315
    [No Abstract]   [Full Text] [Related]  

  • 25. Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004-2005.
    Richter SS; Heilmann KP; Dohrn CL; Riahi F; Beekmann SE; Doern GV
    Clin Infect Dis; 2009 Feb; 48(3):e23-33. PubMed ID: 19115971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The molecular epidemiology of Streptococcus pneumoniae with quinolone resistance mutations.
    Richter SS; Heilmann KP; Beekmann SE; Miller NJ; Rice CL; Doern GV
    Clin Infect Dis; 2005 Jan; 40(2):225-35. PubMed ID: 15655739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Streptococcus pneumoniae. The appearance of antibiotic resistance].
    Arredondo-GarcĂ­a JL
    Gac Med Mex; 1997; 133(2):155-7. PubMed ID: 9254288
    [No Abstract]   [Full Text] [Related]  

  • 28. Antimicrobial activity among multidrug-resistant Streptococcus pneumoniae isolated in the United States, 2001-2005.
    Thornsberry C; Brown NP; Draghi DC; Evangelista AT; Yee YC; Sahm DF
    Postgrad Med; 2008 Sep; 120(3 Suppl 1):32-8. PubMed ID: 18931469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increase in penicillin resistance of invasive Streptococcus pneumoniae in Brazil after 1999.
    Brandileone MC; Casagrande ST; Guerra ML; Zanella RC; de Andrade AL; Di Fabio JL
    J Antimicrob Chemother; 2005 Aug; 56(2):437-9. PubMed ID: 15972313
    [No Abstract]   [Full Text] [Related]  

  • 30. Longitudinally tracking fluoroquinolone resistance and its determinants in penicillin-susceptible and -nonsusceptible Streptococcus pneumoniae isolates in Hong Kong, 2000 to 2005.
    Ip M; Chau SS; Chi F; Cheuk ES; Ma H; Lai RW; Chan PK
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2192-4. PubMed ID: 17371818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multidrug-resistant Streptococcus pneumoniae.
    Foster DA; Heller ST; Young JK
    N Engl J Med; 2001 Apr; 344(17):1329; author reply 1330-1. PubMed ID: 11336021
    [No Abstract]   [Full Text] [Related]  

  • 32. Pneumococcal bacteraemia in Belgium (1994 2004): the pre-conjugate vaccine era.
    Flamaing J; Verhaegen J; Vandeven J; Verbiest N; Peetermans WE
    J Antimicrob Chemother; 2008 Jan; 61(1):143-9. PubMed ID: 17999974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New quinolones--a fresh answer to the pneumococcus.
    Cubbon MD; Masterton RG
    J Antimicrob Chemother; 2000 Dec; 46(6):869-72. PubMed ID: 11102402
    [No Abstract]   [Full Text] [Related]  

  • 34. Resurgence of the multiresistant pneumococcus in the United States: a commentary.
    Klugman KP; McGee L
    Pediatr Infect Dis J; 2007 Jun; 26(6):473-4. PubMed ID: 17529861
    [No Abstract]   [Full Text] [Related]  

  • 35. The public health ramifications of pneumococcal resistance.
    Reinert RR
    Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():1-3. PubMed ID: 19366361
    [No Abstract]   [Full Text] [Related]  

  • 36. Are fluoroquinolone-susceptible isolates of Streptococcus pneumoniae really susceptible? A comparison of resistance mechanisms in Canadian isolates from 1997 and 2003.
    Schurek KN; Adam HJ; Siemens CG; Hoban CJ; Hoban DJ; Zhanel GG
    J Antimicrob Chemother; 2005 Oct; 56(4):769-72. PubMed ID: 16126779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activity of gemifloxacin against Streptococcus pneumoniae and Haemophilus influenzae.
    Morrissey I; Tillotson G
    J Antimicrob Chemother; 2004 Feb; 53(2):144-8. PubMed ID: 14729748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emergence and epidemiology of fluoroquinolone-resistant Streptococcus pneumoniae strains from Italy: report from the SENTRY Antimicrobial Surveillance Program (2001-2004).
    Deshpande LM; Sader HS; Debbia E; Nicoletti G; Fadda G; Jones RN;
    Diagn Microbiol Infect Dis; 2006 Mar; 54(3):157-64. PubMed ID: 16423493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A review of Streptococcus pneumoniae infection treatment failures associated with fluoroquinolone resistance.
    Fuller JD; Low DE
    Clin Infect Dis; 2005 Jul; 41(1):118-21. PubMed ID: 15937772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interspecies recombination in type II topoisomerase genes is not a major cause of fluoroquinolone resistance in invasive Streptococcus pneumoniae isolates in the United States.
    Pletz MW; McGee L; Beall B; Whitney CG; Klugman KP
    Antimicrob Agents Chemother; 2005 Feb; 49(2):779-80. PubMed ID: 15673766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.